Most Children With Conjunctivitis Have Rx for Topical Antibiotics Filled
10 Jul 2024
Clinical Result
WEDNESDAY, July 10, 2024 -- More than two-thirds of children with conjunctivitis have a prescription filled for topical antibiotics within one day of an ambulatory care visit, according to a research letter published online June 27 in JAMA Ophthalmology.
Daniel J. Shapiro, M.D., M.P.H., from the University of California, San Francisco, and colleagues examined prescription of topical antibiotic treatment and the association of treatment with subsequent health care use among individuals aged 1 to 17 years with ambulatory care encounters who had a conjunctivitis diagnosis. A total of 44,793 ambulatory care encounters were included.
The researchers found that after 69 percent of encounters, topical antibiotics were dispensed within one day. Topical antibiotics were dispensed less frequently after visits to eye clinics, for children aged 6 to 11 years, and for viral conjunctivitis (34, 66, and 28 percent, respectively). After 3.2 percent of index encounters, ambulatory care revisits for conjunctivitis occurred within 14 days. After 1.4 percent of index encounters, all-cause revisits with a same-day antibiotic dispensation occurred. No association was seen for topical antibiotic treatment with ambulatory care revisits for conjunctivitis or revisits with same-day topical antibiotic dispensation in a multivariable analysis. Hospitalizations for conjunctivitis and emergency department revisits occurred for 0.03 and 0.12 percent of children, respectively, with no differences seen across exposure groups.
"Revisits and new antibiotic dispensations were rare, regardless of initial topical antibiotic treatment, suggesting that not receiving antibiotics may not be associated with additional health care use," the authors write. "Given that antibiotics may not be associated with improved outcomes or change in subsequent health care use and are associated with adverse effects and antibiotic resistance, efforts to reduce overtreatment of acute infectious conjunctivitis are warranted."
Abstract/Full Text (subscription or payment may be required)
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Targets
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.